Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use

PURPOSE: The absence of specific treatments for COVID-19 leads to an intense global effort in the search for new therapeutic interventions and better clinical outcomes for patients. This review aimed to present a selection of accepted studies that reported the activity of antidepressant drugs belong...

Descripción completa

Detalles Bibliográficos
Autores principales: Foletto, Vitória Segabinazzi, da Rosa, Taciéli Fagundes, Serafin, Marissa Bolson, Hörner, Rosmari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360648/
https://www.ncbi.nlm.nih.gov/pubmed/35943535
http://dx.doi.org/10.1007/s00228-022-03372-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360648/
https://www.ncbi.nlm.nih.gov/pubmed/35943535
http://dx.doi.org/10.1007/s00228-022-03372-5

Ejemplares similares